Deb Nathan Klatte

Deb Nathan Klatte has a comprehensive work experience in the pharmaceutical and biotechnology industry. They have held various positions with notable companies such as Generation Bio, Shire, Cubist Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Pfizer Research Technology Center, Cadus Pharmaceutical Corporation, and the University of Chicago. Deb's most recent position is as Vice President of Translational Biology at Generation Bio since December 2021. Prior to that, they held roles such as Senior Director and Director of Pharmacology at Generation Bio, Associate Director of Pharmacology at Shire, and Senior Scientist II at Cubist Pharmaceuticals. They also served as Director of Integrative Biology at Boehringer Ingelheim Pharmaceuticals. In addition, Deb has a strong academic background and completed a postdoctoral research fellowship at the University of Chicago.

Deb Nathan Klatte obtained a Bachelor of Science degree in Biology & Computer Science from Bucknell University, where they studied from 1981 to 1985. Deb then pursued a Ph.D. in Tumor Cell Biology at Northwestern University from 1985 to 1990.